Finkelstein Thompson LLP Announces Investigation of Allied Defense Group Inc.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Allied Defense Group Inc. ("ADG” or the "Company”) (NYSE Amex:ADG) arising from the Company’s announcement of its intent to be acquired by Chemring Group PLC ("Chemring”).

On January 19, 2010, ADG announced its plan to merge with Chemring. Under the terms of the merger agreement, ADG shareholders will receive $7.25 in cash for every share of ADG common stock they own in a transaction valued at $59 million.

The investigation is focused on the potential unfairness of the consideration to be paid to ADG shareholders as well as the potential unfairness of the process by which the ADG Board of Directors is addressing the transaction.

If you are interested in discussing your rights as an ADG shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.